Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.Nature Chemical Biology|December 19, 2017
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradationCalla M Olson, Baishan Jiang, Michael A Erb, et al.Nature Communications|January 31, 2017
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsFlorencia Cayrol, Pannee Praditsuktavorn, Tharu M Fernando, et al.Nature Communications|February 10, 2017
Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.Cell Chemical Biology|March 26, 2019
Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle PhenotypeCalla M Olson, Yanke Liang, Alan Leggett, et al.Cell Chemical Biology|April 18, 2025
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancersNicholas Kwiatkowski, Tong Liang, Zhe Sha, et al.Blood|March 6, 2023
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myelomaYao Yao, Jessica Fong Ng, Woojun Daniel Park, et al.Nature Communications|April 17, 2019
CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylationMalgorzata Krajewska, Ruben Dries, Andrew V Grassetti, et al.Pageof 4